These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30089856)

  • 1. The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2018 Dec; 98(12):1549-1561. PubMed ID: 30089856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
    Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
    Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
    Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
    Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
    Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
    Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2016 Sep; 96(9):1004-15. PubMed ID: 27501049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells.
    Pan M; Hou L; Zhang J; Zhao D; Hua J; Wang Z; He J; Jiang H; Hu H; Zhang L
    Mol Cell Biochem; 2018 Apr; 441(1-2):63-76. PubMed ID: 28887716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
    Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
    Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells promote cell invasion and migration and autophagy-induced epithelial-mesenchymal transition in A549 lung adenocarcinoma cells.
    Luo D; Hu S; Tang C; Liu G
    Cell Biochem Funct; 2018 Mar; 36(2):88-94. PubMed ID: 29372557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells and their Derived Exosomes Promote Malignant Phenotype of Polyploid Non-Small-Cell Lung Cancer Cells through AMPK Signaling Pathway.
    Wang L; Ouyang M; Xing S; Zhao S; Liu S; Sun L; Yu H
    Anal Cell Pathol (Amst); 2022; 2022():8708202. PubMed ID: 35419253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2.
    Liang Y; Zhang D; Li L; Xin T; Zhao Y; Ma R; Du J
    Stem Cell Res Ther; 2020 Feb; 11(1):87. PubMed ID: 32102682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial-mesenchymal transition and stem-like reprogram.
    Yan C; Chang J; Song X; Qi Y; Ji Z; Liu T; Yu W; Wei F; Yang L; Ren X
    Aging (Albany NY); 2021 Mar; 13(7):9780-9800. PubMed ID: 33744858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
    Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
    Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.
    Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L
    Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.